BIOMED CENTRAL LIMITED
Company Information
- Company Number
- 03680030
- Registered Address
- The Campus, 4 Crinan Street, London, United Kingdom, N1 9XW
- Status
- Active
- Employee Count
- 78
- Turnover
- £112,046,000
- EBITDA
- £67,105,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 8 December 1998
- Nature of Business
- 58141 - Publishing of learned journals
- Industries
- Media And Publishing
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Company Review
Trend Analysis
The data for BIOMED CENTRAL LIMITED shows that the average time taken to pay invoices has fluctuated over the past three periods, with a decrease in 2019 and 2021 and an increase in 2020.
Volatility Analysis
The data for BIOMED CENTRAL LIMITED also shows volatility in the percentage of invoices paid within 30 days, with a high of 88% in 2019 and a low of 74% in 2019. There is also volatility in the percentage of invoices paid later than 60 days, with a high of 9% in 2019 and a low of 2% in 2020.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2021 - 30 Jun 2021 | 05 Aug 2021 | 22 | 87% | 9% | 4% | 41% |
| 01 Jul 2020 - 31 Dec 2020 | 20 Feb 2021 | 33 | 88% | 6% | 6% | 35% |
| 01 Jan 2020 - 30 Jun 2020 | 05 Aug 2020 | 23 | 86% | 12% | 2% | 44% |
| 01 Jul 2019 - 31 Dec 2019 | 31 Jan 2020 | 33 | 88% | 8% | 4% | 55% |
| 01 Jan 2019 - 30 Jun 2019 | 24 Jul 2019 | 21 | 74% | 18% | 9% | 50% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 33 | 85% | 9% | 6% | 61% |
| 01 Jan 2018 - 30 Jun 2018 | 31 Jul 2018 | 25 | 77% | 20% | 3% | 71% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Our most used standard payment terms are 30 days from invoice date for regular vendors.
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
45
Dispute Resolution Process
Vendors can contact our global support department Globalapsupport@springernature.com They will answer all questions regarding the status of an invoice/payment and resolve any dispute with payment amounts and deductions received in their bank account. Any other disputes regarding delivery needs to be resolved with the employee who bought the goods or services.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
BIOMED CENTRAL LIMITED is a UK-based company that specializes in open access scientific publishing. It was founded in 2000 and is currently owned by Springer Nature, a leading global research, educational, and professional publisher.
The company's main activity is publishing peer-reviewed, open access journals in the fields of biology, medicine, and health. This means that their articles are freely available online to all readers, without any subscription fees. This promotes the dissemination of scientific research and knowledge, making it accessible to a wider audience.
In addition to their publishing services, BIOMED CENTRAL LIMITED also offers a range of tools and services to support the research community. This includes article processing and publication services, data sharing and archiving, and author services such as language editing and manuscript formatting.
One of the key focuses of BIOMED CENTRAL LIMITED is sustainability. They have a dedicated sustainability program, which includes initiatives to reduce their carbon footprint, promote responsible waste management, and support biodiversity conservation. They also offer a range of sustainability resources and guidelines to their authors, encouraging them to publish their research in an environmentally responsible manner.
The company is led by a team of experienced and knowledgeable individuals, including the CEO, Dr. Iain Hrynaszkiewicz, who has a background in open access publishing and research integrity. The registered office address for BIOMED CENTRAL LIMITED is located in London, UK.
In conclusion, BIOMED CENTRAL LIMITED is a leading open access publisher in the field of biomedical research, with a strong commitment to sustainability. Their range of products and services, along with their dedicated team, make them a valuable resource for the scientific community. For more information, please visit their website at https://www.biomedcentral.com/.
